Quantcast

Latest Selexis SA Stories

2013-12-17 23:04:19

CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) December 17, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today data from the Company’s SURE CHO-Mplus™ Libraries will be presented at the 13th Annual PepTalk Conference, January 13-17, 2014 at the Renaissance Hotel & Palm Springs...

2013-11-19 23:20:50

Former Quintile executive brings more than 15 years of life science and regulatory knowledge to Selexis Geneva, Switzerland (PRWEB) November 19, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the hire of Marco Bocci, PhD, DPharm, as Director of European Sales and Business Development. Dr. Bocci joins Selexis from Quintiles and will be...

2013-10-24 23:21:55

Dr. Igor Fisch to Present Data on Using the SURE CHO-Mplus Combinatorial Library to Address a Broad Range of Protein Production Bottlenecks Geneva, Switzerland (PRWEB) October 24, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company’s president and CEO, Igor Fish, Ph.D., will present, “Selexis SURE CHO-Mplus™ Libraries: Custom...

2013-07-31 23:26:04

CSO to Present Data on Using the SURE CHO-Mplus Combinatorial Library to Address a Broad Range of Protein Production Bottlenecks Geneva, Switzerland (PRWEB) July 31, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company will present data on the SURE CHO-Mplus™ Library at the Bioprocessing Summit being held August 19 – 23 at the...

2013-07-16 23:04:49

Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing Geneva, Switzerland (PRWEB) July 16, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that representatives from the Company will be participating in the BIO Taiwan 2013...

2013-05-29 23:14:13

Selexis CSO Demonstrates How the Selexis SURE CHO-Mplus Library Can Improve Product Yield in Mammalian Cell Lines Geneva, Switzerland (PRWEB) May 29, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today it will host a free webinar to educate scientists and researchers about the newly launched SURE CHO-Mplus Library to address a broad range of...

2013-05-20 23:15:02

Selexis´ co-founder and scientific advisory board member will present, “Engineering the CHO Genome for Improved Transgene Integration and Expression” Geneva, Switzerland (PRWEB) May 20, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that the Company´s co-founder will present data on the Company´s core technology at...

2013-04-23 23:20:09

Company to Present Data on recently launched Selexis SURE CHO-Mplus Libraries Geneva, Switzerland (PRWEB) April 23, 2013 Geneva, Switzerland - April 23, 2013 — Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company´s vice present of business development, Andrew Sandford, will be speaking on The Selexis SURE CHO-Mplus Libraries: Next...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.